Particulate matter of particular interest.
D001194:Asbestos / Q000008:administration & dosage*; D005374:Filtration; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D007275:Injections, Intravenous / Q000009:adverse effects*; D010288:Parenteral Nutrition / Q000009:adverse effects; D010316:Particle Size; D012996:Solutions / Q000592:standards
D012996:Solutions; D001194:Asbestos